An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex and manufactured by Pfizer, significantly reduced recurrence of adenomas -- or pre-malignant colon tumors -- within three years of previous adenoma removal.
A former District of Mission councillor has come away from a potentially fatal bout of colon cancer with a new appreciation for life, and offering some rarely heard comments these days: positive words about health care in the Fraser Valley.
Government scientists turned regular blood cells into tumor attackers that wiped out all signs of cancer in two men with advanced melanoma. The striking finding, unveiled Thursday, marks an important step in the quest for gene therapy for cancer.
BOSTON, Aug. 31 (UPI) -- Two U.S. studies say Pfizer's painkiller Celebrex can slow the recurrence of polyps in the colon for those at a higher risk of developing colon cancer.
HOUSTON - An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex® and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved